<DOC>
	<DOCNO>NCT01446770</DOCNO>
	<brief_summary>The objective study evaluate initial safety efficacy MF-4181 , hydrogel scaffold , reduction volume , appearance , and/or symptom associate keloid scar subject undergo surgical revision keloid scar .</brief_summary>
	<brief_title>Evaluation Initial Safety Efficacy Keloid Lesions Treated With MF-4181</brief_title>
	<detailed_description />
	<mesh_term>Keloid</mesh_term>
	<criteria>Male female subject 15 50 year age least one keloid scar ear . ( If ear keloid , ear may treat EMatrix ) . Keloids undergone two surgical revision ( laser , cryotherapy surgery ) Keloids present ≥ 1 year . The keloid must measure ≥ 0.5 cm extend onto portion head , neck , face . Able willing give write informed consent . ( Age 1517 must write informed consent legal guardian ) . Willing comply follow schedule minimum 6 month . Subjects history prior treatment study site prior treatment keloid previous 6 week . Pregnant plan become pregnant course study . Heart disease history congestive heart failure . Advanced poorly control diabetes . Current history heavy smoking ( i.e. , 10 pack year ) Active local infection treatment site and/or systemic infection . History active central nervous system disease . History fever , migraine headache , and/or recurrent upper respiratory infection . Active collagen vascular disease vasculitis , e.g. , systemic lupus erythematosus , polyarthritis , dermatomyositis , systemic scleroderma thrombotic thrombocytopenic purpura . Unwilling unable return followup visit . Unwilling refrain use scar treatment therapy/scar improve product , study , include steroid injection . Regular , continuous use systemic corticosteroid therapy topical corticosteroid use area treat . Current participation participation within last 3 month study investigational drug , device , biologic . Unable unwilling follow postoperative instruction . Known hypersensitivity MF4181 , collagen , dextran , constituent material . Known hypersensitivity animalbased product Previous participation study avoid multiple enrollment individual subject .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>